Henry Han
LightNews LightNews
banner
hancardiomd.bsky.social
Henry Han
@hancardiomd.bsky.social
650 followers 120 following 120 posts
Cardiologist MBBS, MD, FACC, FESC | Physician-Sci & Researcher MPH | #HeartFailure 🧑‍⚕️| #HFA & #EACVI Committee @escardio | Content Catalyst in @TCTMD
Posts Replies Media Videos
hancardiomd.bsky.social
The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology

onlinejcf.com/article/S107...
@drmarthagulati.bsky.social @dranulala.bsky.social @jcardfail.bsky.social
August 13, 2025 at 11:44 PM
hancardiomd.bsky.social
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the #HFA of the ESC

@escardio.bsky.social onlinelibrary.wiley.com/doi/10.1002/...

@vietheartpa.bsky.social @anastasiasmihaili.bsky.social @cardioobdoc.bsky.social @erinmichos.bsky.social
August 13, 2025 at 11:00 PM
hancardiomd.bsky.social
The invisible costs of heart failure: a societal toll

academic.oup.com/eurheartj/ad...

@escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social
June 12, 2025 at 1:15 AM
hancardiomd.bsky.social
The impact of federal actions on academic medicine and the U.S. health care system

www.aamc.org/about-us/aam...

@cardioobdoc.bsky.social @arghavansallesmd.medsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social
June 12, 2025 at 1:00 AM
hancardiomd.bsky.social
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis

#Colchicine significantly reduced #MACE in patients with vascular disease: pooled HR 0.75 (95% CI 0.56–0.93) across 6 RCTs (n=21,800).

#CardioSky @escardio.bsky.social
May 2, 2025 at 10:06 PM
hancardiomd.bsky.social
Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association

#CCU #CICU #JACC #CardioSky @jaccjournals.bsky.social @americanheart.bsky.social @accintouch.bsky.social
April 19, 2025 at 8:07 PM
hancardiomd.bsky.social
Phase 3 trial of PO #Orforglipron ; lowering A1C by an average of 1.3% to 1.6% across doses

Once-daily oral pill reduced weight by an average 16.0 lbs (7.9%) at the highest dose in a key S’ endpoint

@tctmd.bsky.social @mmamas1973.bsky.social @shelleyzieroth.bsky.social @drmarthagulati.bsky.social
April 18, 2025 at 1:23 PM
hancardiomd.bsky.social
Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social #RVFailure #HeartFailure #CardioEd @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @mmamas1973.bsky.social @mirvz.bsky.social
April 18, 2025 at 1:22 PM
hancardiomd.bsky.social
#Cancer and #CVD are intertwined, with inflammation and a dysregulated immune system being common contributors

Shared Mechanisms in Cancer and #CVD : #S100A8/9 and the #NLRP3 #Inflammasome

#CardioSky #OncoSky @cardioobdoc.bsky.social @novitham.bsky.social @pnatarajanmd.bsky.social
April 18, 2025 at 1:27 AM
hancardiomd.bsky.social
This study aimed to characterize HF with supranormal EF (HFsnEF) using different LVEF cutoffs (35%, 55%, and 70% for men, and 40%, 60%, and 75% for women).
onlinelibrary.wiley.com/doi/full/10....
@escardio.bsky.social @hvanspall.bsky.social @erinmichos.bsky.social @docbhardwaj.bsky.social
April 15, 2025 at 10:05 PM
hancardiomd.bsky.social
Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure

#EJHF @escardio.bsky.social
#CardioSky @shelleyzieroth.bsky.social @jimjanuzzi.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social
April 15, 2025 at 10:00 PM
hancardiomd.bsky.social
#Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the #FINEARTS-HF trial

onlinelibrary.wiley.com/doi/full/10.... @escardio.bsky.social #CardioSky @
April 13, 2025 at 4:31 PM
hancardiomd.bsky.social
#Aldosterone-targeted therapies: early implementation in resistant #HTN and #CKD

Reflecting on the fundamentals and exploring future directions

academic.oup.com/eurheartj/ad...
#CardioSky @escardio.bsky.social #EHJ @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social
April 13, 2025 at 4:19 PM
hancardiomd.bsky.social
This State-of-the-Art Review addresses the current understanding on the pathophysiological link between #CVD and #CKD, clinical implications and challenges

academic.oup.com/eurheartj/ad...

#CardioSky
@escardio.bsky.social
@cardioobdoc.bsky.social @hvanspall.bsky.social @novitham.bsky.social
April 10, 2025 at 12:38 AM
hancardiomd.bsky.social
Lower extremity lymphatic flow is associated with diuretic response in acute heart failure

In 65 AHF patients, lymphatic flow (via ICG lymphangiography) predicted diuretic response.

#AHF #CardioSky #Lymphatics #AHF @shelleyzieroth.bsky.social @escardio.bsky.social @drrajivsankar.bsky.social
April 9, 2025 at 11:59 PM
hancardiomd.bsky.social
Efficacy, Safety and Mechanistic Impact of a #HeartFailure Guideline-Directed Medical Therapy Clinic

#JACCHF #CardioSky #GDMT

www.jacc.org/doi/full/10....

@jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
April 9, 2025 at 11:50 PM
hancardiomd.bsky.social
Prognostic value of left atrioventricular coupling index in heart failure

In 478 HF patients (LVEF <50%), higher #LACI (≥30.9%) was linked to worse outcomes.

academic.oup.com/ehjcimaging/... @escardio.bsky.social @cardioobdoc.bsky.social @vassv.bsky.social @shelleyzieroth.bsky.social
April 8, 2025 at 9:23 PM
hancardiomd.bsky.social
Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation

onlinelibrary.wiley.com/doi/10.1002/... #Impella #CardioSky #CardiogenicShock #LVADs
@drrajivsankar.bsky.social @shelleyzieroth.bsky.social @cardioobdoc.bsky.social @hvanspall.bsky.social
April 5, 2025 at 12:45 AM
hancardiomd.bsky.social
Conduction system pacing: promoting the physiology to prevent HF

Background and Clinical perspectives of HBP and LBBP area in HF
link.springer.com/article/10.1...

#HF #CardioSky #CardioEd @cardioobdoc.bsky.social @drrajivsankar.bsky.social @annakatebarton.bsky.social @vietheartpa.bsky.social
April 5, 2025 at 12:43 AM
hancardiomd.bsky.social
Effectiveness of a Simplified Checklist to Overcome the Inertia of Treatment Implementation in #ACS Patients with High Comorbidity Burden

#CardioSky @cardioobdoc.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @drrajivsankar.bsky.social @gbiondizoccai.bsky.social
April 4, 2025 at 7:05 PM
hancardiomd.bsky.social
What's new in heart failure? March 2025

onlinelibrary.wiley.com/doi/full/10....
#EJHF #CardioSky @escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @erinmichos.bsky.social @novitham.bsky.social
April 3, 2025 at 10:56 PM
hancardiomd.bsky.social
#ZENITH Phase 3 RCT: #Sotatercept in High-Risk PAH

✅ Reduced primary endpoint events: 17.4% vs. 54.7% (HR 0.24, P < 0.001)
✅ Lower mortality: 8.1% vs. 15.1%
✅ Fewer PAH 🏥: 9.3% vs. 50.0%
✅ Lower lung transplant rate: 1.2% vs. 7.0%
🩸 Most common AEs: epistaxis, telangiectasia

@nejm.org
April 3, 2025 at 10:51 PM
hancardiomd.bsky.social
Sex differences in cardiac remodelling in ischaemic #cardiomyopathy and functional #MR : impact on prognosis

#EHJIMP @escardio.bsky.social @sarahmoharem.bsky.social @jgrapsa.bsky.social @cardioobdoc.bsky.social @victoriadelgadomd.bsky.social
academic.oup.com/ehjimp/artic...

#CardioSky
March 28, 2025 at 12:43 PM
hancardiomd.bsky.social
Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does HF With Supranormal EF Exist? Data From the 🇸🇪 #HeartFailure Registry

www.ahajournals.org/doi/10.1161/... @ahascience.bsky.social @gbiondizoccai.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social
March 27, 2025 at 8:51 PM
hancardiomd.bsky.social
Direct-to-Physician Marketing and Uptake of OMT for #HFrEF

📌60% of general & 50% of #AHF cardiologists received ARNI/#SGLT2i marketing (2019-2021)

📌#ARNI meals in 2020 led to +43% to +109% higher prescribing in 2021 for general cardiologist

#HeartFailure #GDMT
www.jacc.org/doi/10.1016/...
March 24, 2025 at 12:34 AM